Aptevo Therapeutics achieves major breakthrough with mipletamig in acute myeloid leukemia

Aptevo Therapeutics has unveiled remarkable findings from Cohort 1 of its RAINIER clinical trial for mipletamig, a bispecific antibody aimed at tackling acute myeloid leukemia ... Read More